Sossana Delibasi

15PUBLICATIONS
42CO-AUTHORS
PharmacogenomicsMedical virologyNanomedicinePsychosocial aspects of childbirth and perinatal mental healthMedical genetics (excl. cancer genetics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 14, 2026
Benefit of selinexor dose reduction on outcomes with selinexor, bortezomib and dexamethasone in patients with lenalidomide-refractory multiple myeloma: Subgroup analysis of the BOSTON trial.

Sosana Delimpasi, Ivan Špička, Jason P Butler

|Apr 10, 2026
Real-World Outcomes in NPM1-Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse.

Panagiotis Tsirigotis, Maria Garofalaki, Ioanna Lazana

|Jan 22, 2026
Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre.

Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis

|Nov 27, 2025
Patient Perception of the Relevance of Quality-of-Life Questionnaires in Waldenström Macroglobulinaemia: An International Survey.

Jahanzaib Khwaja, Sotirios Bristogiannis, Ibrahim Tohidi-Esfahani

|Jun 03, 2025
Characteristics and Survival Outcomes of Solitary Plasmacytomas: A 30-Year Experience of the Greek Myeloma Study Group on 175 Patients.

Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira

|Jul 18, 2024
A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma.

Meletios A Dimopoulos, Daniel Coriu, Sosana Delimpasi

Pageof 3

Frequent Collaborators

10 joint publications

Meletios-Athanasios Dimopoulos

7 joint publications

Eirini Katodritou

6 joint publications

Ioannis Ntanasis-Stathopoulos

6 joint publications

Evangelos Terpos